HER2-positive breast cancer (HER2+-BC) is characterized by the overexpression and/or amplification of the ERBB2 gene encoding the epidermal growth factor receptor 2, which occurs in ≈15–20% of all breast cancers (BC) [1, 2]. Here, ERBB2 is linked to breast carcinoma.